Spearhead Capital Advisors, LLC Regenxbio Inc. Transaction History

Spearhead Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$24.62 - $34.31 $293,174 - $408,563	-11,908 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$30.19 - $40.28 $20,227 - $26,987	670 Added 5.96%	11,908 $389,000
Q3 2021 Oct 27, 2021	BUY	$29.09 - $45.68 $15,592 - $24,484	536 Added 5.01%	11,238 $471,000
Q2 2021 Aug 10, 2021	BUY	$32.46 - $40.48 $54,987 - $68,573	1,694 Added 18.81%	10,702 $416,000
Q1 2021 Apr 28, 2021	BUY	$33.61 - $49.95 $302,758 - $449,949	9,008 New	9,008 $307,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.